메뉴 건너뛰기




Volumn 24, Issue 2, 2005, Pages 222-225

Use of bivalirudin, a direct thrombin inhibitor, and its reversal with modified ultrafiltration during heart transplantation in a patient with heparin-induced thrombocytopenia

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HIRUDIN; HIRULOG; LEPIRUDIN; THROMBIN INHIBITOR;

EID: 13444306585     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.11.401     Document Type: Article
Times cited : (38)

References (18)
  • 1
    • 0036916631 scopus 로고    scopus 로고
    • Heparin induced thrombocytopenia: A common complication in cardiac transplant recipients
    • Hourigan L.A., Walters D.L., Keck S.A., Dec G.W. Heparin induced thrombocytopenia a common complication in cardiac transplant recipients. J Heart Lung Transplant. 21:2002;1283-1289
    • (2002) J Heart Lung Transplant , vol.21 , pp. 1283-1289
    • Hourigan, L.A.1    Walters, D.L.2    Keck, S.A.3    Dec, G.W.4
  • 2
    • 0036213008 scopus 로고    scopus 로고
    • Heparin-induced thrombocytopenia: An overview
    • Kelton J.G. Heparin-induced thrombocytopenia an overview. Blood Rev. 16:2002;77-80
    • (2002) Blood Rev , vol.16 , pp. 77-80
    • Kelton, J.G.1
  • 3
    • 0034866893 scopus 로고    scopus 로고
    • Heparin-induced thrombocytopenia: Natural history diagnosis, and management
    • Deitcher S.R., Carman T.L. Heparin-induced thrombocytopenia natural history diagnosis, and management. Vasc Med. 6:2001;113-119
    • (2001) Vasc Med , vol.6 , pp. 113-119
    • Deitcher, S.R.1    Carman, T.L.2
  • 4
    • 0036301759 scopus 로고    scopus 로고
    • Heparin-induced thrombocytopenia: Temporal pattern of thrombocytopenia in relation initial use or reexposure to heparin
    • Lubenow N., Kempf R., Eichner A., Eichler P., Carlsson L.E., Greinacher A. Heparin-induced thrombocytopenia temporal pattern of thrombocytopenia in relation initial use or reexposure to heparin. Chest. 122:2002;37-42
    • (2002) Chest , vol.122 , pp. 37-42
    • Lubenow, N.1    Kempf, R.2    Eichner, A.3    Eichler, P.4    Carlsson, L.E.5    Greinacher, A.6
  • 5
    • 0036320729 scopus 로고    scopus 로고
    • Current agents for the treatment of patients with heparin-induced thrombocytopenia
    • Warkentin T.E. Current agents for the treatment of patients with heparin-induced thrombocytopenia. Curr Opin Pulmon Med. 8:2002;405-412
    • (2002) Curr Opin Pulmon Med , vol.8 , pp. 405-412
    • Warkentin, T.E.1
  • 7
    • 0035853125 scopus 로고    scopus 로고
    • Recombinant hirudin in clinical practice: Focus on lepirudin
    • Greinacher A., Lubenow N. Recombinant hirudin in clinical practice focus on lepirudin. Circulation. 103:2001;1479-1484
    • (2001) Circulation , vol.103 , pp. 1479-1484
    • Greinacher, A.1    Lubenow, N.2
  • 8
    • 0036771617 scopus 로고    scopus 로고
    • Fondaparinux (Arixtra) a new anticoagulant
    • Giamgrande P.L. Fondaparinux (Arixtra) a new anticoagulant. Int J Clin Pract. 56:2002;615-617
    • (2002) Int J Clin Pract , vol.56 , pp. 615-617
    • Giamgrande, P.L.1
  • 9
    • 0036034818 scopus 로고    scopus 로고
    • Danaparoid: A review of its use in thromboembolic and coagulation disorders
    • Ibbotson T., Perry C.M. Danaparoid a review of its use in thromboembolic and coagulation disorders. Drugs. 62:2002;2283-2314
    • (2002) Drugs , vol.62 , pp. 2283-2314
    • Ibbotson, T.1    Perry, C.M.2
  • 10
    • 0028014541 scopus 로고
    • Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen
    • Greinacher A., Potzsch B., Amiral J., Dummel V., Eicher A., Mueller-Eckhardt C. Heparin-associated thrombocytopenia isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost. 71:1994;247-251
    • (1994) Thromb Haemost , vol.71 , pp. 247-251
    • Greinacher, A.1    Potzsch, B.2    Amiral, J.3    Dummel, V.4    Eicher, A.5    Mueller-Eckhardt, C.6
  • 12
    • 0034091906 scopus 로고    scopus 로고
    • Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation
    • Kawada T., Kitagawa H., Hoson M., Okada Y., Shiomura J. Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation. Hematol Oncol Clin N Am. 14:2000;445-457
    • (2000) Hematol Oncol Clin N Am , vol.14 , pp. 445-457
    • Kawada, T.1    Kitagawa, H.2    Hoson, M.3    Okada, Y.4    Shiomura, J.5
  • 14
    • 0034741623 scopus 로고    scopus 로고
    • Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass
    • von Segesser L.K., Mueller X., Marty B., Horisberger J., Corno A. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass. Perfusion. 16:2001;411-416
    • (2001) Perfusion , vol.16 , pp. 411-416
    • Von Segesser, L.K.1    Mueller, X.2    Marty, B.3    Horisberger, J.4    Corno, A.5
  • 15
    • 0035783623 scopus 로고    scopus 로고
    • The use of argatroban as an anticoagulation for cardiopulmonary bypass in cardiac operations
    • Furukawa K., Ohteki H., Hirahara K., et al. The use of argatroban as an anticoagulation for cardiopulmonary bypass in cardiac operations. J Thorac Cardiovasc Surg. 122:2001;1255-1256
    • (2001) J Thorac Cardiovasc Surg , vol.122 , pp. 1255-1256
    • Furukawa, K.1    Ohteki, H.2    Hirahara, K.3
  • 16
    • 0036212053 scopus 로고    scopus 로고
    • Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis
    • Willet M.L., de Denus S., Spinler S.A. Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis. Pharmacotherapy. 22:2002;492-499
    • (2002) Pharmacotherapy , vol.22 , pp. 492-499
    • Willet, M.L.1    De Denus, S.2    Spinler, S.A.3
  • 17
    • 0035983918 scopus 로고    scopus 로고
    • Bivalirudin pharmacokinetics and pharmacodynamics: Effect of renal function, dose, and gender
    • Robson R., White H., Aylward P., Frampton C. Bivalirudin pharmacokinetics and pharmacodynamics effect of renal function, dose, and gender. Clin Pharmacol Ther. 71:2002;433-439
    • (2002) Clin Pharmacol Ther , vol.71 , pp. 433-439
    • Robson, R.1    White, H.2    Aylward, P.3    Frampton, C.4
  • 18
    • 0027209030 scopus 로고
    • Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty
    • Ferguson D.J., Willerson J.T., Strony J., et al. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty. Circulation. 87:1993;1622-1629
    • (1993) Circulation , vol.87 , pp. 1622-1629
    • Ferguson, D.J.1    Willerson, J.T.2    Strony, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.